Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00269373 |
Recruitment Status
:
Completed
First Posted
: December 23, 2005
Last Update Posted
: February 22, 2012
|
Sponsor:
Rigshospitalet, Denmark
Information provided by (Responsible Party):
Gedske Daugaard, Rigshospitalet, Denmark
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date | December 22, 2005 | |||
First Posted Date | December 23, 2005 | |||
Last Update Posted Date | February 22, 2012 | |||
Study Start Date | December 2005 | |||
Actual Primary Completion Date | February 2012 (Final data collection date for primary outcome measure) | |||
Current Primary Outcome Measures | Not Provided | |||
Original Primary Outcome Measures | Not Provided | |||
Change History | Complete list of historical versions of study NCT00269373 on ClinicalTrials.gov Archive Site | |||
Current Secondary Outcome Measures | Not Provided | |||
Original Secondary Outcome Measures | Not Provided | |||
Current Other Outcome Measures | Not Provided | |||
Original Other Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title | Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors | |||
Official Title | PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors | |||
Brief Summary | Is PET-CT scan better than PET or CT alone in diagnosing primary tumours in patients with unknown primary tumors? Can information obtained with PET-CT replace other clinical and radiological investigations? Is PET/CT cost-effective? | |||
Detailed Description | Patients who fulfill the international definition of unknown primary tumors can be included, except:
|
|||
Study Type | Observational | |||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
|||
Target Follow-Up Duration | Not Provided | |||
Biospecimen | Not Provided | |||
Sampling Method | Non-Probability Sample | |||
Study Population | Patients with unknown tumors | |||
Condition | Unknown Primary Tumor | |||
Intervention | Procedure: PET-CT
no drugs included |
|||
Study Groups/Cohorts | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status | Completed | |||
Actual Enrollment |
136 | |||
Original Enrollment | Same as current | |||
Actual Study Completion Date | February 2012 | |||
Actual Primary Completion Date | February 2012 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
|
|||
Sex/Gender |
|
|||
Ages | 18 Years to 75 Years (Adult, Senior) | |||
Accepts Healthy Volunteers | No | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | Denmark | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number | NCT00269373 | |||
Other Study ID Numbers | 01 283694 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement | Not Provided | |||
Responsible Party | Gedske Daugaard, Rigshospitalet, Denmark | |||
Study Sponsor | Rigshospitalet, Denmark | |||
Collaborators | Not Provided | |||
Investigators |
|
|||
PRS Account | Rigshospitalet, Denmark | |||
Verification Date | February 2012 |